Strength
200 mg/mL
Manufacturer
UCB, Inc.NDC
50474071079
Classification
Brand
Dosage Form
INJECTION, SOLUTION
Route
SUBCUTANEOUS
Last Updated
6/17/2026
Active Ingredients
CERTOLIZUMAB PEGOLApproval Type
Biologic (BLA)
FDA Application
BLA125160On Market Since
5/14/2009
Pharmacological Classes
Price Statistics
The NADAC for CIMZIA 2X200 MG/ML SYRINGE KIT has been published 657 times since Nov 28, 2013, and over the history we have for it it has risen 148.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $6120.2638 per EA |
|---|---|
| All-time high | $6120.2638 (Jun 24, 2026) |
| All-time low | $2442.0936 (Dec 18, 2013) |
| 52-week high | $6120.2638 |
| 52-week low | $5816.3608 |
| Median price | $4474.0753 |
| Average price | $4334.4957 |
| Largest weekly change | +9.9% (Jan 14, 2015) |
| Weeks tracked | 657 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 1 NADAC-published product sharing this drug's active ingredient, strength, and dosage form across 1 manufacturer (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 1% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of CIMZIA 2X200 MG/ML SYRINGE KIT?
The current National Average Drug Acquisition Cost (NADAC) for CIMZIA 2X200 MG/ML SYRINGE KIT, manufactured by UCB, Inc., is $6120.2638 per EA (NDC 50474071079), effective Jun 24, 2026.
How has the price of CIMZIA 2X200 MG/ML SYRINGE KIT changed over time?
Over the history we have for it, the NADAC for CIMZIA 2X200 MG/ML SYRINGE KIT has risen 148.9%. It has been tracked across 657 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for CIMZIA 2X200 MG/ML SYRINGE KIT?
Since Nov 28, 2013, the NADAC for CIMZIA 2X200 MG/ML SYRINGE KIT has ranged from a low of $2442.0936 (Dec 18, 2013) to a high of $6120.2638 (Jun 24, 2026), with a median of $4474.0753 per EA.
Are there cheaper alternatives to CIMZIA 2X200 MG/ML SYRINGE KIT?
Yes. 1 NADAC-published product shares the same active ingredient, strength, and dosage form. The lowest-priced option, CIMZIA 2X200 MG/ML(X3)START KT, is $6072.5137 per EA — about 1% below CIMZIA 2X200 MG/ML SYRINGE KIT.
Who manufactures CIMZIA 2X200 MG/ML SYRINGE KIT?
CIMZIA 2X200 MG/ML SYRINGE KIT (NDC 50474071079) is labeled by UCB, Inc., and CMS classifies it as a brand product.
Related Drugs
Same classification